NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...

Scar-driven changes in joint tissue may underlie treatment resistance in rheumatoid arthritis, opening the door to new ...

Please provide your email address to receive an email when new articles are posted on . The next new treatment for rheumatoid arthritis could come from the unlikeliest of sources. Researchers based at ...

For patients with rheumatoid arthritis and reduced kidney function, remission after drug therapy is less likely than for ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. First of all, I think that we struggle with ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

Over the last decade, the outlook for patients with rheumatoid arthritis (RA) has improved, but there is growing interest in ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

Methotrexate is a first-line rheumatoid arthritis drug that reduces pain and swelling. It may also slow disease progression and help prevent joint damage. Many people notice less pain, swelling, and ...

What’s the Goal of Treat to Target? Usually, your goal for RA treatment is remission. This is when you have no clinical signs of active inflammation. RA remission is based on your blood tests, ...